AMPWP
GILD icon

Alvarez & Marsal Private Wealth Partners’s Gilead Sciences GILD Stock Holding History

Alvarez & Marsal Private Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,979
Closed -$276K – 142
2026
Q1 		$276K Buy
+1,979
New +$277K 0.04% 133

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alvarez & Marsal Private Wealth Partners's GILD Position: Q2 2026 in Review

Alvarez & Marsal Private Wealth Partners sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,979 shares — an estimated $276K sold.

Alvarez & Marsal Private Wealth Partners first reported a position in GILD in Q1 2026 and held it in 1 quarter. The position peaked at $276K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Alvarez & Marsal Private Wealth Partners reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Alvarez & Marsal Private Wealth Partners sold 1,979 Gilead Sciences shares in Q2 2026, an estimated $276K.
  • Alvarez & Marsal Private Wealth Partners first reported a position in Gilead Sciences in Q1 2026 and held it in 1 quarter.
  • Alvarez & Marsal Private Wealth Partners's Gilead Sciences position peaked at $276K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Alvarez & Marsal Private Wealth Partners's 13F filing for Q2 2026, filed 14 Aug 2026.